联合检测MMP-7VEGF-D和KAI1在胰腺癌预后判断中的价值

The Value of Combined Detection with MMP-7,VEGF-D and KAI1 (MVK) in Prognosis of Pancreatic Carcinoma

  • 摘要: 目的 :探讨将基质金属蛋白酶-7(MMP-7)、血管内皮生长因子-D(VEGF-D)和KAI1进行联合检测(简称MVK)在胰腺癌预后判断中的价值。 方法 :应用免疫组化法检测胰腺癌中MMP-7、VEGF-D和KAI1的表达,分析MVK的联合表达模式对预后的影响。 结果 :MVK的联合表达模式中无不利预后因素组,其胰腺癌术后中位生存时间为12个月;单个不利预后因素组,其术后中位生存时间为8个月;两个不利预后因素组,其术后中位生存时间为6个月;3个不利预后因素组,其术后中位生存时间为5个月。各组间均具有显著性差异(P=0.0045,P=0.0003,P=0.0015)。多因素分析结果表明,MVK为胰腺癌独立预后指标。 结论 :MVK的联合表达模式对更准确反映胰腺癌的预后有价值,值得进一步研究。

     

    Abstract: Objective :To explore the value of combined detection with MMP-7,VEGF-D andKAI1 (MVK) in the prognosis of pancreatic carcinoma. Methods : By immunohistochemistry, the ex-pression of MMP-7,VEGF-D and KAI1 was respectively studied and the relationship between co-ex-pression mode of MVK and the survival time of patients with pancreatic carcinoma was analysed. Re-Sults :Different modes of MVK were of statistical significance with patient median survival time(12months, 8 months, 6 months, 5 months, respectively. P=0.0045, P=0.0003, P=0.0015, respectively).COX regression revealed that coexpression mode of MVK is independent prognostic factors in pancreat-ic carcinoma. Conclusions :Combined analysis of MVK may lead to a more reliable prognostic estima-tion, and it deserves further investigation.

     

/

返回文章
返回